-
Join Us! Testsealabs at CMEF 2025 (Guangzhou) Booth 20.1S17 to Explore Diagnostic Technology
Testsealabs, a leading name in the global medical technology industry, is gearing up to make a standout appearance at the 92nd China International Medical Equipment (Autumn) Expo (CMEF)—one of the world’s premier healthcare technology gatherings. Set to run from September 26-29, 2025, the expo wi...Read more -
Hangzhou Testsealabs to Showcase Core Precision Diagnostic Products at Pharmedi Vietnam 2025
Hangzhou Testsealabs, a leading player in the global precision diagnostic industry, is thrilled to announce its participation in Pharmedi Vietnam 2025—Southeast Asia’s premier medical and healthcare exhibition. Backed by Vietnam’s Ministry of Health and recognized by the Vietnam Medical Device A...Read more -
Understanding the Vibro Cholerae O139 and O1 Combo Test
The Vibro Cholerae O139(VC O139) and O1(VC O1) Combo Test utilizes an immunochromatography technique to identify two significant strains of cholera bacteria. This test is crucial for timely cholera detection, allowing health authorities to implement swift interventions. Effective use of the Vibr...Read more -
Dominican Republic Delegation Visits Hangzhou Testsea Biotechnology, Exploring Future Collaborations in IVD Diagnostics
HANGZHOU, China – [Date of Visit, August 22, 2025] – Hangzhou Testsea Biotechnology Co., Ltd. (Testsealabs), a leading manufacturer of in vitro diagnostic (IVD) rapid tests, was honored to host a distinguished delegation of clients from the Dominican Republic last week. The visit served to streng...Read more -
Innovative IVD Detection Reagents Revolutionize Arbovirus Diagnosis
Zika virus, a member of the Flaviviridae family, is primarily transmitted to humans through the bite of an infected Aedes mosquito, such as Aedes aegypti and Aedes albopictus. The virus was first identified in 1947 in the Zika Forest of Uganda, where it was isolated from a rhesus monkey. For deca...Read more -
Malaria: An Overview and Advanced Rapid Test Kits Powered by Immune Colloidal Gold Technique
What is Malaria? Malaria is a life-threatening disease caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes. The parasites follow a complex life cycle: upon entering the body, they first invade liver cells to multiply, then release sp...Read more -
Beyond Mosquito Nets: Why Post-Protection Testing is Critical in the 2025 Arbovirus Outbreak
Beyond Mosquito Nets: Why Post-Protection Testing is Critical in the 2025 Arbovirus Outbreak Geneva, August 6, 2025 – As the World Health Organization (WHO) warns of accelerating chikungunya outbreaks across 119 countries, health experts are emphasizing a critical gap in mosquito-borne disease ...Read more -
WHO Sounds Alarm on Chikungunya Fever as Foshan’s Outbreak Surges
In a concerning development, the World Health Organization (WHO) has sounded the alarm on chikungunya fever, a mosquito-borne disease, as the situation in Foshan, China, continues to escalate. As of July 23, 2025, Foshan has reported over 3,000 confirmed cases of chikungunya fever, all of which a...Read more -
Chikungunya Outbreak: Navigating Symptom Overlaps, Global Travel Risks, and Diagnostic Solutions
1. The 2025 Shunde Outbreak: A Wake-Up Call for Travel Health In July 2025, Shunde District, Foshan, became the epicenter of a localized Chikungunya outbreak triggered by an overseas imported case. By July 15, just one week after the first confirmed infection, 478 mild cases had been reported—hi...Read more -
Testsealabs and Strategic Partner Join Hands with Nobel Laureate to Write a New Chapter in Cell and Gene Therapy
Recently, Mr. Zhou Bin, General Manager of Testsealabs, was invited to attend the contract renewal ceremony between strategic partner Hailiang Biotechnology Co., Ltd. and Professor Randy Schekman, Nobel Laureate in Physiology or Medicine and member of the US National Academy of Sciences. This ren...Read more -
Testsealabs Set to Shine at Asia Health Medlab Asia 2025
Hangzhou Testsea Biotechnology Co., Ltd., renowned as Testsealabs, is thrilled to announce its participation in the highly anticipated Asia Health Medlab Asia, a premier event in the medical laboratory industry. The exhibition will take place from July 16th to 18th, 2025, in Malaysia, and...Read more -
International Clients Explore Testsealabs: Showcasing Excellence in Biotechnology
In a significant display of international collaboration and business growth, Hangzhou Testsea Biotechnology Co., Ltd., known as Testsealabs, recently hosted clients from Ukraine and Somalia. The visit provided an in – depth look into the company’s operations, highlighting its cutting ...Read more
